Sabby Management’s Tetraphase Pharmaceuticals TTPH Stock Holding History
Bought
Maintained
Sold
Other funds holding TTPH
Sabby Management's TTPH Position: Q2 2020 in Review
Sabby Management sold out of Tetraphase Pharmaceuticals (TTPH) in Q2 2020, closing a stake of 667,000 shares — an estimated $854K sold.
Sabby Management first reported a position in TTPH in Q3 2015 and held it in 2 quarters. The position peaked at $854K in Q1 2020. 26 funds tracked by Wall St. Rank hold TTPH as of Q2 2020.
- Sabby Management reported no remaining Tetraphase Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
- Sabby Management sold 667,000 Tetraphase Pharmaceuticals shares in Q2 2020, an estimated $854K.
- Sabby Management first reported a position in Tetraphase Pharmaceuticals in Q3 2015 and held it in 2 quarters.
- Sabby Management's Tetraphase Pharmaceuticals position peaked at $854K in Q1 2020.
- 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals as of Q2 2020.
Based on Sabby Management's 13F filing for Q2 2020, filed 14 Aug 2020.